Kim et al., 2001 - Google Patents
Inhibitory effect on immunoglobulin E production in vivo and in vitro by Siegesbeckia glabrescensKim et al., 2001
- Document ID
- 9636310853130268760
- Author
- Kim H
- Lee J
- Won J
- Park E
- Chae H
- Kim H
- Kim C
- Baek S
- Publication year
- Publication venue
- Phytotherapy Research
External Links
Snippet
Elevated levels of immunoglobulin (Ig) E are associated with immediate‐type allergic reactions. The effect of an aqueous extract of Siegesbeckia glabrescens (Compositae) whole plants (SGWP) on in vivo and in vitro IgE production was studied in mice. SGWP dose …
- 238000004519 manufacturing process 0 title abstract description 38
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100511550B1 (en) | Pharmaceutical composition comprising the extract of Actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | |
| Wachholz et al. | Induction of ‘blocking’IgG antibodies during immunotherapy. | |
| Rolinck-Werninghaus et al. | Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen | |
| Carvalho et al. | Worms and allergy | |
| AU2009219793B2 (en) | Activation of innate and adaptive immune responses by a ginseng extract | |
| Kim et al. | Inhibitory effect on immunoglobulin E production in vivo and in vitro by Siegesbeckia glabrescens | |
| Kim et al. | Inhibition of immunoglobulin E production by Poncirus trifoliata fruit extract | |
| US20100040714A1 (en) | Asthma/Allergy Therapy that Targets T-lymphoctyes and/or Eosinophils | |
| Kim et al. | Asiasari radix inhibits immunoglobulin E production on experimental models in vitro and in vivo | |
| Banche et al. | Improvement of clinical response in allergic rhinitis patients treated with an oral immunostimulating bacterial lysate: in vivo immunological effects | |
| WO2011012240A2 (en) | Lipopeptides for therapy and prophylaxis of allergic illnesses | |
| US6521263B1 (en) | Immunomodulatory factors for immunosuppresant and antiallergic treatment | |
| AU2006204554A1 (en) | Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine | |
| CA2577165C (en) | Oral killed vaccines and method for providing same | |
| Movérare | Immunological mechanisms of specific immunotherapy with pollen vaccines: implications for diagnostics and the development of improved vaccination strategies | |
| AU3182900A (en) | Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils | |
| AU2005274680B2 (en) | Oral killed vaccines and method for providing same | |
| Jorde | Modulation of allergic airway inflammation by Staphylococcus aureus enterotoxin B in a mouse model | |
| Yunginger | In Vitro Tests to Monitor Efficacy of Immunotherapy | |
| US20140212500A1 (en) | Compositions containing diverse natural antigens and uses thereof in balancing immune responses | |
| Hemmer et al. | 184 Presence of IgE antibodies against crossreacting carbohydrate determinants in double-posivity to honey bee and yellow jacket venom | |
| JP2004168765A (en) | Hay fever treatment | |
| Rhinitis | GK SCADDING | |
| Koytak | Effects of Nigella sativa extracts on the cytokine production of antigen-stimulated pbmc of allergic subjects |